Abstract
The endocannabinoid system (ECS) critically regulates stress responsivity and emotional behavior throughout development. It regulates anxiety-like behaviors in humans and animal models. In addition, it is sensitive to early life stress at the gene expression level in a sex-dependent and region-dependent manner, and these changes are already evident in the adolescent brain. The ECS modulates the neuroendocrine and behavioral effects of stress, and is also capable of being affected by stress exposure itself. Early life stress interferes with the development of corticolimbic circuits, a major location of endocannabinoid receptors, and increases vulnerability to adult psychopathology. Early life stress alters the ontogeny of the ECS, resulting in a sustained deficit in its function, particularly within the hippocampus. Specifically, exposure to early stress results in bidirectional changes in anandamide and 2-AG tissue levels within the amygdala and hippocampus and reduces hippocampal endocannabinoid function at puberty. CB1 receptor densities across all brain regions are downregulated later in life following exposure to early life stress. Manipulations affecting the glucocorticoid and the endocannabinoid systems persistently adjust individual emotional responses and synaptic plasticity. This review aims to show the bidirectional trajectories of endocannabinoid modulation of emotionality in reaction to early life stress.
Original language | English |
---|---|
Pages (from-to) | 143-152 |
Number of pages | 10 |
Journal | Developmental Psychobiology |
Volume | 63 |
Issue number | 2 |
Early online date | 18 Dec 2019 |
DOIs | |
State | Published - Mar 2021 |
Bibliographical note
Publisher Copyright:© 2019 Wiley Periodicals, Inc.
Funding
Parts of the research in AW's laboratory are supported by Europacific Medical Ltd., the Israel Science Foundation and the Israel Ministry of Science and Technology. The funding sources had no influence on the content of this review. Parts of the research in AW's laboratory are supported by Europacific Medical Ltd., the Israel Science Foundation and the Israel Ministry of Science and Technology. The funding sources had no influence on the content of this review.
Funders | Funder number |
---|---|
Europacific Medical Ltd. | |
Israel Science Foundation | |
Ministry of science and technology, Israel |
Keywords
- CB1 receptors
- corticolimbic
- early life stress
- endocannabinoid system